3D Global Biotech, Inc. engages in the research and development of biological three dimensional printing technology. It also sells medical equipment. It provides cranial implant customized services, entrusted technical services, and oral medical materials customized services. It offers soft tissue and hard tissue reconstruction medical products including bio-hydrogel ink and corneal epithelial reconstruction, orthopedic reconstruction, dental and jaw reconstruction, and skull reconstruction products. The company was founded on December 26, 2014 and is headquartered in New Taipei, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company